Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Case report

Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report

Authors: Zhenyu Pan, Guozi Yang, Tingting Yuan, Xiaochuan Pang, Yongxiang Wang, Limei Qu, Lihua Dong

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Leptomeningeal metastasis, which results from metastasis of tumors to the arachnoid and pia mater, can lead to the dissemination of tumor cells throughout the subarachnoid space via the cerebral spinal fluid, and frequently with a poor prognosis. The primary tumor in adults is most often breast cancer, lung cancer, or melanoma. Although leptomeningeal metastasis due to cholangiocarcinoma has been reported, to the best of our knowledge there is no cytologically confirmed report of leptomeningeal metastasis from hepatocellular carcinoma.

Case presentation

We herein report a case of leptomeningeal metastasis from hepatocellular carcinoma in a 53-year-old woman with concomitant systemic metastases to the lung, bone, brain, kidney, adrenal gland, subcutaneous tissues, and abdominal pelvis. The neurological symptoms of the patient were relieved after treatment with methotrexate intra-cerebral spinal fluid chemotherapy concurrent with whole brain radiotherapy.

Conclusion

To our knowledge this is the first report of leptomeningeal metastasis from hepatocellular carcinoma confirmed by cytology. Treatment with methotrexate intra-cerebral spinal fluid chemotherapy concurrent with whole brain radiotherapy was effective.
Appendix
Available only for authorised users
Literature
1.
go back to reference Terada T, Maruo H: Unusual extrahepatic metastatic sites from hepatocellular carcinoma. Int J Clin Exp Pathol. 2013, 6 (5): 816-820.PubMedPubMedCentral Terada T, Maruo H: Unusual extrahepatic metastatic sites from hepatocellular carcinoma. Int J Clin Exp Pathol. 2013, 6 (5): 816-820.PubMedPubMedCentral
2.
go back to reference Ngan H, Peh WC: Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol. 1997, 52 (1): 36-40. 10.1016/S0009-9260(97)80303-0.CrossRefPubMed Ngan H, Peh WC: Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol. 1997, 52 (1): 36-40. 10.1016/S0009-9260(97)80303-0.CrossRefPubMed
4.
go back to reference Amador A, Monforte NG, Bejarano N, Martí J, Artigau E, Navarro S, Fuster J: Cutaneous metastasis from hepatocellular carcinoma as the first clinical sign. J Hepatobiliary Pancreat Surg. 2007, 14 (3): 328-330. 10.1007/s00534-006-1141-1.CrossRefPubMed Amador A, Monforte NG, Bejarano N, Martí J, Artigau E, Navarro S, Fuster J: Cutaneous metastasis from hepatocellular carcinoma as the first clinical sign. J Hepatobiliary Pancreat Surg. 2007, 14 (3): 328-330. 10.1007/s00534-006-1141-1.CrossRefPubMed
5.
go back to reference Jiang XB, Ke C, Zhang GH, Zhang XH, Sai K, Chen ZP, Mou YG: Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer. 2012, 12: 49-10.1186/1471-2407-12-49.CrossRefPubMedPubMedCentral Jiang XB, Ke C, Zhang GH, Zhang XH, Sai K, Chen ZP, Mou YG: Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer. 2012, 12: 49-10.1186/1471-2407-12-49.CrossRefPubMedPubMedCentral
6.
go back to reference Huffman JL, Yeatman TJ, Smith JB: Leptomeningeal carcinomatosis: a sequela of cholangiocarcinoma. Am Surg. 1997, 63 (4): 310-313.PubMed Huffman JL, Yeatman TJ, Smith JB: Leptomeningeal carcinomatosis: a sequela of cholangiocarcinoma. Am Surg. 1997, 63 (4): 310-313.PubMed
7.
go back to reference Le Rhun E, Taillibert S, Chamberlain MC: Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013, 4 (Suppl 4): S265-288.PubMedPubMedCentral Le Rhun E, Taillibert S, Chamberlain MC: Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013, 4 (Suppl 4): S265-288.PubMedPubMedCentral
9.
go back to reference Zauderer M, Krug LM, Pietanza MC, O'Rourke D: Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy. J Thorac Oncol. 2010, 5 (10): 1716-1717. 10.1097/JTO.0b013e3181f1cc32.CrossRefPubMed Zauderer M, Krug LM, Pietanza MC, O'Rourke D: Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy. J Thorac Oncol. 2010, 5 (10): 1716-1717. 10.1097/JTO.0b013e3181f1cc32.CrossRefPubMed
10.
go back to reference Chamberlain M, Kormanik P: Leptomeningeal metastases due to melanoma. Int J Oncol. 1996, 9 (3): 505-510.PubMed Chamberlain M, Kormanik P: Leptomeningeal metastases due to melanoma. Int J Oncol. 1996, 9 (3): 505-510.PubMed
11.
go back to reference Kanda M, Tateishi R, Yoshida H, Sato T, Masuzaki R, Ohki T, Imamura J, Goto T, Yoshida H, Hamamura K, Obi S, Kanai F, Shiina S, Omata M: Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver Int. 2008, 28 (9): 1256-1263. 10.1111/j.1478-3231.2008.01864.x.CrossRefPubMed Kanda M, Tateishi R, Yoshida H, Sato T, Masuzaki R, Ohki T, Imamura J, Goto T, Yoshida H, Hamamura K, Obi S, Kanai F, Shiina S, Omata M: Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver Int. 2008, 28 (9): 1256-1263. 10.1111/j.1478-3231.2008.01864.x.CrossRefPubMed
12.
go back to reference Sherman M: Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010, 30 (1): 3-16. 10.1055/s-0030-1247128.CrossRefPubMed Sherman M: Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010, 30 (1): 3-16. 10.1055/s-0030-1247128.CrossRefPubMed
13.
go back to reference Han JH, Kim DG, Park JC, Chung HT, Paek SH, Chung YS: Little response of cerebral metastasis from hepatocellular carcinoma to any treatments. J Korean Neurosurg Soc. 2010, 47 (5): 325-331. 10.3340/jkns.2010.47.5.325.CrossRefPubMedPubMedCentral Han JH, Kim DG, Park JC, Chung HT, Paek SH, Chung YS: Little response of cerebral metastasis from hepatocellular carcinoma to any treatments. J Korean Neurosurg Soc. 2010, 47 (5): 325-331. 10.3340/jkns.2010.47.5.325.CrossRefPubMedPubMedCentral
14.
go back to reference Chang L, Chen YL, Kao MC: Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol. 2004, 62 (2): 172-177. 10.1016/j.surneu.2003.10.002.CrossRefPubMed Chang L, Chen YL, Kao MC: Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol. 2004, 62 (2): 172-177. 10.1016/j.surneu.2003.10.002.CrossRefPubMed
15.
go back to reference Chamberlain MC: Leptomeningeal metastasis. Curr Opin Oncol. 2010, 22 (6): 627-635. 10.1097/CCO.0b013e32833de986.CrossRefPubMed Chamberlain MC: Leptomeningeal metastasis. Curr Opin Oncol. 2010, 22 (6): 627-635. 10.1097/CCO.0b013e32833de986.CrossRefPubMed
16.
go back to reference Leal T, Chang JE, Mehta M, Robins HI: Leptomeningeal metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev. 2011, 7 (4): 319-327. 10.2174/157339411797642597.CrossRefPubMedPubMedCentral Leal T, Chang JE, Mehta M, Robins HI: Leptomeningeal metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev. 2011, 7 (4): 319-327. 10.2174/157339411797642597.CrossRefPubMedPubMedCentral
17.
go back to reference Kim A, Lee JE, Jang WS, Lee SJ, Park S, Kang HJ, Lee SS: A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-kappaB signaling. Leuk Res. 2012, 36 (3): 350-357. 10.1016/j.leukres.2011.07.027.CrossRefPubMed Kim A, Lee JE, Jang WS, Lee SJ, Park S, Kang HJ, Lee SS: A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-kappaB signaling. Leuk Res. 2012, 36 (3): 350-357. 10.1016/j.leukres.2011.07.027.CrossRefPubMed
18.
go back to reference Qin S, Bai Y, Lim HY, Thongprasert S, Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, Lee JH, Sun Y: Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol. 2013, 31 (28): 3501-3508. 10.1200/JCO.2012.44.5643.CrossRefPubMed Qin S, Bai Y, Lim HY, Thongprasert S, Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, Lee JH, Sun Y: Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol. 2013, 31 (28): 3501-3508. 10.1200/JCO.2012.44.5643.CrossRefPubMed
19.
go back to reference Lok AS, Lai CL: Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus fnfection: role in the early detection of hepatocellular carcinoma. Hepatology. 1989, 9 (1): 110-115. 10.1002/hep.1840090119.CrossRefPubMed Lok AS, Lai CL: Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus fnfection: role in the early detection of hepatocellular carcinoma. Hepatology. 1989, 9 (1): 110-115. 10.1002/hep.1840090119.CrossRefPubMed
Metadata
Title
Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report
Authors
Zhenyu Pan
Guozi Yang
Tingting Yuan
Xiaochuan Pang
Yongxiang Wang
Limei Qu
Lihua Dong
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-399

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine